Drug Database
BE

bepotastine besilate (Talion OD)

✓ Approved

Mitsubishi Tanabe Pharma Corporation · HRH1 · Small Molecule

What is bepotastine besilate?

bepotastine besilate is a small molecule developed by Mitsubishi Tanabe Pharma Corporation. It is approved for therapeutic indications via oral (po).

Drug Profile

Brand NamesTalion OD
CompanyMitsubishi Tanabe Pharma Corporation
Drug ClassSmall Molecule
Molecular TargetHRH1
RouteOral (PO)
StatusApproved

Mechanism of Action

Molecular Targets

bepotastine besilate acts on 1 molecular target:

HRH1histamine receptor H1 (HH1R, H1R)
Want deeper analysis?Noah AI can explain complex mechanisms and compare to similar drugs.

Therapeutic Indications

bepotastine besilate is developed for 4 unique indications across 3 therapeutic areas.

Therapeutic AreaConditionPhase
Immune system disordersHypersensitivity✓ Approved
Skin and subcutaneous tissue disordersPruritus✓ Approved
Respiratory, thoracic and mediastinal disordersRhinitis allergic✓ Approved
Skin and subcutaneous tissue disordersUrticaria✓ Approved

Related Research Articles

PubMedNPJ science of food2026-09-10

Machine learning reveals structural determinants of odor detection thresholds and identifies high-potency food odorants.

Hou Xin X, Zhou Zhilei Z, Shi Peiqin P, Wang Yan Y et al.

Odor detection threshold (ODT) quantifies the perceptual potency of volatile compounds and is a key parameter in flavor chemistry. It is widely used to identify key food odorants, calculate odor activity values, and evaluate the contribution of volatiles to overall aroma perception. However, reliable ODT data remain sparse and inconsistent, and are unavailable for many volatiles detected in metabolomics analyses, complicating the identification of key food odorants and the quantitative interpretation of aroma contributions. Here we developed a machine learning framework to predict aqueous ODTs using a curated dataset of 1003 compounds, achieving a test-set R² of 0.83. External validation with 177 independently measured compounds supported the model's predictive utility, with 87.0% of predictions falling within a 10-fold deviation and 97.7% within a 100-fold deviation. Structural analysis suggested that aliphatic acids and nitrogen-containing compounds exhibit relatively high ODTs, whereas acyclic sulfur compounds, methoxypyrazines, haloanisoles, and exocyclic esters display low ODTs. Model-guided screening prioritized candidate high-potency odorants, and human sensory evaluation of 12 representative compounds provided preliminary prospective support for the prioritization workflow. These results provide a computational framework for prioritizing potent food odorants and offer data-driven insights into molecular features associated with odor potency in food aroma chemistry.

PubMedEnvironmental pollution (Barking, Essex : 1987)2026-09-08

Integrating molecular properties and olfactory receptor binding affinities for identifying environmental odorants.

Zhan Jun J, Wang Yujing Y, Shen Yilin Y, Lü Fan F et al.

Odorous volatile compounds released from waste and wastewater treatment, soil remediation, industrial manufacturing, and livestock operations have become a growing environmental and public health concern. However, identifying key odor compounds within complex emissions remains a fundamental challenge, as odor impact is governed not solely by chemical concentration, but by the odor detection thresholds (ODTs) and odor qualities. Although machine-learning approaches have shown promise in predicting odor characteristics of compounds, existing models primarily rely on molecular physicochemical properties while overlooking the biological interactions between odorants and the human olfactory system. Here, a computational framework integrating molecular descriptors, structural fingerprints, and simulated molecule-olfactory receptor (OR) binding affinities was developed to predict ODTs and odor qualities of volatile compounds. Our framework outperforms conventional physicochemical-based models, with particularly strong discriminative capability for garlic, alliaceous, and sulfurous odors-compound classes commonly associated with odor pollution. The molecular polarity, structural complexity, and OR binding affinity are further identified as prior factors for odor perception. Key ORs governing ODT and odor quality predictions are separately pinpointed. By bridging odorant-OR interaction and molecular information, this framework offers a practical tool for screening unknown environmental odorants, supporting targeted odor pollution management, regulatory threshold setting, and development of environmental monitoring strategies.

PubMedScientifica2026-08-28

Quality by Design-Driven Formulation Development of Cannabidiol Orally Disintegrating Tablets.

Monton Chaowalit C, Kulvanich Poj P, Sucontphunt Apirada A, Suksaeree Jirapornchai J et al.

The development of cannabidiol (CBD) orally disintegrating tablets (ODTs) is effective in treating anxiety in a patient-friendly manner. The application of Quality by Design (QbD) enhances the efficiency and robustness of the pharmaceutical development of CBD ODTs. The objective of this work was to develop a formulation for CBD ODTs using a QbD-driven approach. Quality target product profile, critical quality attributes, and an initial risk assessment were identified and evaluated. Subsequently, a Box-Behnken design was employed to analyze the effects of varied compression force, the quantity of microcrystalline cellulose, and the quantity of croscarmellose sodium to create a design space and control space. Results indicated that the design and control spaces produced tablets with hardness ranging from 4 to 6 kg-force, a disintegration time (DT) ≤ 30 s, and a friability ≤ 1%. All formulations contained 4% CBD (or 10 mg per tablet). The optimal formulation consisted of 35% microcrystalline cellulose and 1% croscarmellose sodium and was compressed at 1400 pounds per square inch. This formulation exhibited a hardness of approximately 5 kg-force, a DT of 13-15 s, and a friability of approximately 0.3%. Verification data confirmed the accuracy of the predictions made by computer software. The content uniformity and assay determined using validated high-performance liquid chromatography ranged between 90% and 100%. CBD was released from the CBD ODT in 1% sodium lauryl sulfate solution, with approximately 76% dissolved within 3 h in the dissolution study. In conclusion, the QbD-driven approach successfully facilitated the formulation development of CBD ODTs with the desired properties for the treatment of anxiety in a patient-friendly manner.

PubMedPharmaceutics2026-08-27

Texture Analyzer-Derived SeDeM-ODT Extension for Bisoprolol Fumarate Orodispersible Tablets: Formulation Discrimination Within a Pharmacopoeial Disintegration-Compliant Space.

Afşin Çağla Ç, Şahbaz Sevinç S, Özer-Önder Setenay S, Uğurlu Timuçin T

Background/Objectives: Conventional SeDeM-ODT screening relies on physicochemical properties and endpoint disintegration tests, which may have limited discriminatory power among formulations that already meet pharmacopoeial disintegration requirements. This study aimed to extend SeDeM-ODT by incorporating texture analyzer-derived descriptors of low-volume liquid disintegration behavior. Methods: Bisoprolol fumarate was used as a low-dose model drug. Selected excipients were characterized using SeDeM and conventional SeDeM-ODT approaches. Texture analyzer distance-time profiles were used to derive swelling efficiency (SE), residue height (RH), and structural transition efficiency (STE), which were converted into SeDeM-compatible parameters. Orodispersible tablets were developed using a two-factor central composite design and evaluated for mechanical properties, pharmacopoeial disintegration, comparative dissolution performance, texture analyzer behavior, and supportive Heckel parameters. Results: All formulations met the pharmacopoeial disintegration criteria and showed rapid drug release under the applied dissolution conditions. Conventional endpoint-based responses showed limited discriminatory value within the investigated formulation space. In contrast, SE, RH, and STE differentiated formulation-dependent swelling, residual structural persistence, and transition toward structural collapse under low-volume liquid controlled-force conditions. MCC-rich formulations generally retained greater residual structure, whereas lactose-rich and/or higher-superdisintegrant formulations showed lower residual persistence. Comparative kinetic fitting and Heckel analysis supported these interpretations but did not independently establish a definitive disintegration mechanism. Conclusions: Incorporating low-volume liquid texture analyzer-derived parameters into SeDeM-ODT improved the comparative interpretation of excipient and formulation behavior. These findings suggest that pharmacopoeial disintegration compliance may coexist with distinct structural pathways not fully captured by conventional endpoints.

PubMedExpert opinion on pharmacotherapy2026-08-24

Evaluating deucrictibant for the treatment of hereditary angioedema.

Bui Van V, Stone Shane S, Bhattarai Bharosha B, Luong Long Hoang LH et al.

Hereditary Angioedema (HAE) is a rare disease affecting approximately 1 in 50,000 people. It results in angioedema of the skin, abdominal tract and upper airway that results in disfiguration, abdominal pain and potential for asphyxia. Early therapies for HAE have significant drug burden due to intravenous administration (C1-inhibitor) or adverse events (androgens); however, newer therapies have reduced injection requirements, and some are oral. Over the past 6 years two oral therapies have been developed for HAE to include berotralstat for long term prophylaxis (LTP) and sebetralstat for on-demand therapy (ODT). Presently, deucrictibant, another oral HAE therapy, is under investigation and appears effective for LTP and ODT. This manuscript summarizes the development, pharmacokinetics, pharmacodynamics, and currently available clinical evidence regarding deucrictibant in HAE management. Deucrictibant is a promising therapeutic agent with a well-defined mechanism of action. Published and ongoing clinical studies demonstrate favorable safety, tolerability, and efficacy profiles for both LTP and ODT, offering a convenient oral alternative that may reduce treatment burden and improve patient quality of life.

PubMedFrontiers in immunology2026-08-13

The evolving treatment landscape for hereditary angioedema in Sweden.

Meisgen Sabrina S, Fischer Franziska F, Li Yinglei Y

Hereditary angioedema (HAE) is a rare genetic disorder, characterized by unpredictable, potentially life-threatening edema attacks. Treatment options include on-demand treatment (ODT) and long-term prophylactic (LTP) therapy. This study describes the HAE treatment landscape in Sweden, focusing on the uptake of recently reimbursed modern LTP therapies and patterns of ODT dispensation as an indirect proxy for breakthrough attacks. This nationwide, longitudinal, registry-based study utilized data from the National Prescribed Drug Register in Sweden describing all dispensed drugs with approved indications for HAE between January 2020-May 2025. During 2024, 245 patients received HAE-specific drugs, with one-third dispensing LTP. Among patients with ≥12 months on modern LTP (n=69) who had at least one ODT dispensation event during their most recent 12 months of treatment (n=46/59 for lanadelumab; n=8/9 for berotralstat), the mean number of ODT packages dispensed-in addition to emergency stock ODT-was 4.3 per patient on lanadelumab and 6.5 per patient on berotralstat. Overall, 22% (n=15/69) of patients receiving modern LTP did not dispense ODT medication during their most recent 12-months of treatment. In total, 22% of patients (n=24/108) with at least one lanadelumab or berotralstat dispensation stopped dispensing modern LTP and switched to alternative LTP or ODT-only treatment options. This study provides valuable insights into real-world dispensation patterns of HAE drugs in Sweden. Despite the availability of modern LTP therapies, there remains relatively high ODT dispensation events, suggesting ongoing unmet need and underscoring the importance of optimizing prophylactic strategies to achieve total disease control.

+1370 more articles available with a free account

Sign up free to view all articles →

Ask about bepotastine besilate